supratentorial tumors
Conditions
Interventions
Group 2:Ultrasound guided scalp nerve block
Group 3:Intravenous infusion of Remazolam
Group 4:the combined use of ultrasound guidedscalp nerve block and intravenous infusion of Remazolam
Sponsors
The Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-65 years old; 2. ASA I-III grade; 3. Surgical removal of supratentorial tumors under general anesthesia; 4. Can understand VAS rating through explanation.
Exclusion criteria
Exclusion criteria: 1. Refusing to sign informed consent form; 2. Those who cannot understand the content of the scale; 3. Unable to cooperate with the researcher due to reasons such as hearing and language barriers; 4. Individuals with contraindications for scalp nerve block, such as abnormal coagulation function, local anesthetic allergy, etc; 5. Individuals with a history of neurological or psychiatric disorders and long-term use of sedatives; 6. Long term use of painkillers for treatment and long-term alcoholism; 7. Severe liver and kidney dysfunction; 8. Patients who undergo any preoperative radiotherapy or chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery Quality QoR-40 Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| numerical rating scale (NRS) score;MAP and HR at the time of noxious events;The dosage of opioid drugs, remifentanil, and propofol during surgery;Recovery Quality QoR-40 Score; | — |
Countries
China
Contacts
Public ContactMaoyin Zhang
The Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed